Li-Ming Gan

Years Active: 2019-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ariella T Cohain, William T Barrington, Daniel M Jordan, Noam D Beckmann, Carmen A Argmann, Sander M Houten, Alexander W Charney, Raili Ermel, Katyayani Sukhavasi, Oscar Franzen, Simon Koplev, Carl Whatling, Gillian M Belbin, Jialiang Yang, Ke Hao, Eimear E Kenny, Zhidong Tu, Jun Zhu, Li-Ming Gan, Ron Do, Chiara Giannarelli, Jason C Kovacic, Arno Ruusalepp, Aldons J Lusis, Johan L M Bjorkegren, Eric E Schadt
An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease. Nature communications 12 (1) (2021)
Li-Ming Gan, Maria Lagerström-Fermér, Leif G Carlsson, Cecilia Arfvidsson, Ann-Charlotte Egnell, Anna Rudvik, Magnus Kjaer, Anna Collén, James D Thompson, John Joyal, Ligia Chialda, Thomas Koernicke, Rainard Fuhr, Kenneth R Chien, Regina Fritsche-Danielson
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes. Nature communications 10 (1) (2019)
Li-Ming Gan, Maria Lagerström-Fermér, Hans Ericsson, Karin Nelander, Eva-Lotte Lindstedt, Erik Michaëlsson, Magnus Kjaer, Maria Heijer, Carl Whatling, Rainard Fuhr
Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers. British journal of clinical pharmacology 85 (4) (2019)

Li-Ming Gan.css-eqlu8i{font-size:small;padding-left:4px;}